Psychologists in Chesterton, IN Accepting Medicare
5 Psychologists found. Showing 1 - 5
 Mrs. Sarah Lerch, ED.S Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 751 E Porter Ave Ste 1, Chesterton, IN 46304 Phone: 219-786-1582 |
Jill Gardner, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 215 W Indiana Ave, Chesterton, IN 46304 Phone: 219-921-0705 Fax: 219-921-0557 |
 Robert James Walsh, PSY.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 1100 S Calumet Rd, Suite 3, Chesterton, IN 46304 Phone: 219-921-5400 Fax: 219-926-8141 |
Steven Mark Kalisch, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 601 Gateway Blvd N, Chesterton, IN 46304 Phone: 219-921-1444 Fax: 219-921-5303 |
Dr. Andrea S Stone, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 215 W Indiana Ave, Chesterton, IN 46304 Phone: 219-921-0705 Fax: 219-921-0557 |
News Archive
Key opinions leaders to discuss role of cyclophosphamide in the field of HSCT
Key opinions leaders in the field of haematopoetic stem cell transplantation (HSCT) will address the role of Cyclophosphamide, an anti-cancer chemotherapy drug, during the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) that will welcome more than 4,500 delegates in the host city of Valencia, Spain from the 3rd to the 6th of April 2016.
New method of stroke treatment led to better patient care
A new method of evaluating and prioritizing treatment for patients with suspected acute stroke, which has been used by the Stockholm health authority since 2017, has led to faster health interventions and better patient care, shows a new study from Karolinska Institutet published in the journal JAMA Neurology.
Borderline personality disorder ‘not linked to psychosis transition'
The presence of borderline personality disorder is not associated with an increased risk for transition to full-blown psychosis in ultra-high risk patients, research shows.
DiaGenic reports operating revenue of NOK 276 thousand for third quarter 2011
DiaGenic has successfully finalized the first clinical study in collaboration with Pfizer, the market leader for Alzheimer's therapeutics sales and Pfizer has confirmed DiaGenic's findings resulting in a press release October 14th.
› Verified 6 days ago
Occupational Therapists
Counselors
Pharmacists
Dentists
Clinical Social Workers
Psychologists